Olmesartanmedoxomil/Hydrochloorthiazide Sandoz (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartanmedoxomil/Hydrochloorthiazide Sandoz, is a angiotensin II receptor blocker presented as a combination tablet for oral use. It treats hypertension, often in combination with lifestyle changes, and may be prescribed for adults. GNH USA supplies Olmesartanmedoxomil/Hydrochloorthiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartanmedoxomil/Hydrochloorthiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil combined with hydrochlorothiazide is indicated for management of high blood pressure within the renin‑angiotensin‑aldosterone system pathway.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with fluid retention: adds diuretic effect to improve blood pressure control. - Resistant hypertension: provides an additional mechanism when monotherapy is insufficient.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Dizziness - Headache - Fatigue - Increased urination - Electrolyte imbalance (low potassium)

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia - Angio‑edema - Liver function abnormalities - Blood cell disorders

Before prescribing Olmesartanmedoxomil/Hydrochloorthiazide Sandoz, clinicians should consider several safety aspects.

- Renal impairment: adjust dose or monitor renal function. - Hepatic impairment: use with caution. - Electrolyte disturbances: monitor potassium and sodium levels. - Pregnancy: contraindicated in the second and third trimesters. - Drug‑specific allergies: avoid if known hypersensitivity to either component. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Olmesartanmedoxomil/Hydrochloorthiazide Sandoz can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Potassium‑rich supplements: increase risk of hyperkalemia. - Aliskiren combined :   ");

Moderate ");

- NSAIDs: may blunt antihypertensive effect. - Lithium: increased lithium levels. - ACE inhibitors/ARBs: additive risk of renal dysfunction. - Antidiabetic drugs: may enhance hypoglycaemic effect.